Skip to main content
Clinical Trials/JPRN-jRCT1010230014
JPRN-jRCT1010230014
Recruiting
未知

Clinical observational retrospective cohort study in patients with pulmonary arterial hypertension using a real-world Japanese claims database.

Arai Yoko0 sites312 target enrollmentJuly 1, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
pulmonary arterial hypertension
Sponsor
Arai Yoko
Enrollment
312
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 1, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Arai Yoko

Eligibility Criteria

Inclusion Criteria

  • 1\. Diagnosed with PAH and prescribed PAH\-targeted drug at the same calendar month in the index period, and claimed another PAH diagnosis during the period from the month following the index to the final follow\-up period (with or without prescription of PAH\-targeted drug)
  • 2\. Aged more than 18 years at the index date
  • 3\. At least 12 months of continuous registration before the index month (including the index month) (Baseline period)
  • 4\. At least 24 months of continuous registration after the index month (Follow\-up period) (Note: For secondary objectives, change the follow\-up periods to 6\-month and 12 month)

Exclusion Criteria

  • 1\. Diagnosed with HIV, portal hypertension, schistosomiasis, CTEPH, or PPHN during baseline period
  • 2\. History of lung transplantation surgery during baseline period

Outcomes

Primary Outcomes

Not specified

Similar Trials